Abstract
MiR-101plays an important role in tumorigenesis. The aim of this study was to estimate diagnostic potential of serummiR-101in bladder cancer.Serum level ofmiR-101in 122 bladder cancer patients and 110 healthy volunteers was detected using quantitative real-time polymerase chain reaction method. The association betweenmiR-101expression and clinicopathological characteristic was analyzed via χ2test. Then receiver operating characteristic (ROC) curve was plotted to evaluate diagnostic value of serummiR-101in bladder cancer.MiR-101expression was statistically down-regulated in bladder cancer patients compared to healthy controls.MiR-101expression was significantly associated with TNM stage (P = .019), pathological grade (P = .006) and lymph node metastasis (P = .010). ROC analysis suggested thatmiR-101had high value in discriminating between bladder cancer patients and healthy individuals with an AUC value of 0.884. The cut-off value for serummiR-101in bladder cancer diagnosis was 1.645, with a sensitivity of 82.0% and a specificity of 80.9%.MiR-101is decreased in bladder cancer patients, and shows negative association with aggressive clinical characteristics.MiR-101may serve as a bio-marker in diagnosing bladder cancer.

This publication has 31 references indexed in Scilit: